Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Follow-Up Study for Exubera (FUSE)

24. september 2012 opdateret af: Pfizer

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Studieoversigt

Status

Afsluttet

Betingelser

Diabetes mellitus

Intervention / Behandling

Detaljeret beskrivelse

Both retrospective and prospective components All subjects who participated in one of the 17 included Exubera clinical trials will be invited to participate in the current study.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

7439

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Argentina
- - Buenos Aires, Argentina, C1426ABP
    - Pfizer Investigational Site
- Buenos Aires
  - Capital Federal, Buenos Aires, Argentina, C1181ACH
    - Pfizer Investigational Site
Australien
- New South Wales
  - Camperdown, New South Wales, Australien, 2050
    - Pfizer Investigational Site
  - Wollongong, New South Wales, Australien, 2500
    - Pfizer Investigational Site
- Queensland
  - Herston, Queensland, Australien, 4029
    - Pfizer Investigational Site
- Victoria
  - Box Hill, Victoria, Australien, 3128
    - Pfizer Investigational Site
  - Melbourne, Victoria, Australien, 3004
    - Pfizer Investigational Site
Belgien
- - Bornem, Belgien, 2880
    - Pfizer Investigational Site
  - Brussels, Belgien, 1070
    - Pfizer Investigational Site
  - Edegem, Belgien, 2650
    - Pfizer Investigational Site
  - Genk, Belgien, 3600
    - Pfizer Investigational Site
  - Leuven, Belgien, 3000
    - Pfizer Investigational Site
  - Liège 1, Belgien, 4000
    - Pfizer Investigational Site
Brasilien
- MG
  - Belo Horizonte, MG, Brasilien, 30150-221
    - Pfizer Investigational Site
- RS
  - Porto Alegre, RS, Brasilien, 90035-170
    - Pfizer Investigational Site
- SP
  - Sao Paulo, SP, Brasilien, 01244-030
    - Pfizer Investigational Site
  - Sao Paulo, SP, Brasilien, 04025-011
    - Pfizer Investigational Site
Canada
- Alberta
  - Calgary, Alberta, Canada, T2L 1K8
    - Pfizer Investigational Site
  - Calgary, Alberta, Canada, T2T 5C7
    - Pfizer Investigational Site
  - Calgary, Alberta, Canada, T3B 0M3
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T5J 3N4
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T6G 2C8
    - Pfizer Investigational Site
  - Edmonton, Alberta, Canada, T6G 2S2
    - Pfizer Investigational Site
  - Red Deer, Alberta, Canada, T6N 6V7
    - Pfizer Investigational Site
- British Columbia
  - Victoria, British Columbia, Canada, V8R 1J8
    - Pfizer Investigational Site
- Manitoba
  - Winnipeg, Manitoba, Canada, R3E 3P4
    - Pfizer Investigational Site
- Newfoundland and Labrador
  - St. John's, Newfoundland and Labrador, Canada, A1A 2E2
    - Pfizer Investigational Site
- Nova Scotia
  - Halifax, Nova Scotia, Canada, B3H 1V7
    - Pfizer Investigational Site
  - Halifax, Nova Scotia, Canada, B3H 2Y9
    - Pfizer Investigational Site
- Ontario
  - Corunna, Ontario, Canada, N0N 1G0
    - Pfizer Investigational Site
  - London, Ontario, Canada, N6A 4V2
    - Pfizer Investigational Site
  - Mississauga, Ontario, Canada, L5M 2V8
    - Pfizer Investigational Site
  - Oakville, Ontario, Canada, L6H 3P1
    - Pfizer Investigational Site
  - Ottawa, Ontario, Canada, K1H 1A2
    - Pfizer Investigational Site
  - Smiths Falls, Ontario, Canada, K7A 4W8
    - Pfizer Investigational Site
  - Thornhill, Ontario, Canada, L4J 8L7
    - Pfizer Investigational Site
  - Toronto, Ontario, Canada, M4N-3M5
    - Pfizer Investigational Site
  - Toronto, Ontario, Canada, M4R 2G4
    - Pfizer Investigational Site
- Quebec
  - Chicoutimi, Quebec, Canada, G7H 5H6
    - Pfizer Investigational Site
  - Gatineau, Quebec, Canada, J8Y 6S9
    - Pfizer Investigational Site
  - Greenfield Park, Quebec, Canada, J4V 2H1
    - Pfizer Investigational Site
  - Laval, Quebec, Canada, H7T 2P5
    - Pfizer Investigational Site
  - Montreal, Quebec, Canada, H3A 1A1
    - Pfizer Investigational Site
  - Sherbrooke, Quebec, Canada, J1H 5N4
    - Pfizer Investigational Site
  - Trois Rivieres, Quebec, Canada, G8T 7A1
    - Pfizer Investigational Site
Danmark
- - Aarhus, Danmark, 8000
    - Pfizer Investigational Site
  - Copenhagen, Danmark, 2400
    - Pfizer Investigational Site
  - Herning, Danmark, 7400
    - Pfizer Investigational Site
Det Forenede Kongerige
- - Bath, Det Forenede Kongerige, BA2 3HT
    - Pfizer Investigational Site
  - Bath, Det Forenede Kongerige, BA2 4BY
    - Pfizer Investigational Site
  - Birmingham, Det Forenede Kongerige, B37 7TR
    - Pfizer Investigational Site
  - Birmingham, Det Forenede Kongerige, B9 5SS
    - Pfizer Investigational Site
  - Bolton, Det Forenede Kongerige, BL3 6TL
    - Pfizer Investigational Site
  - Canterbury, Det Forenede Kongerige, CT1 3HX
    - Pfizer Investigational Site
  - Leicester, Det Forenede Kongerige, LE1 5WW
    - Pfizer Investigational Site
  - Newcastle-upon-Tyne, Det Forenede Kongerige, NE15 6TQ
    - Pfizer Investigational Site
  - Salford, Det Forenede Kongerige, M6 8HD
    - Pfizer Investigational Site
  - Westbury, Det Forenede Kongerige, BA13 3JD
    - Pfizer Investigational Site
- Cornwall
  - Penzance, Cornwall, Det Forenede Kongerige, TR18 4JH
    - Pfizer Investigational Site
  - St. Austell, Cornwall, Det Forenede Kongerige, PL26 7RL
    - Pfizer Investigational Site
- Devon
  - Plymouth, Devon, Det Forenede Kongerige, PL6 8BX
    - Pfizer Investigational Site
- Hertfordshire
  - Letchworth, Hertfordshire, Det Forenede Kongerige, SG6 4UB
    - Pfizer Investigational Site
- Middlesex
  - Ashford, Middlesex, Det Forenede Kongerige, TW15 3EA
    - Pfizer Investigational Site
- Oxford
  - Headington, Oxford, Det Forenede Kongerige, OX3 7LJ
    - Pfizer Investigational Site
- Surrey
  - Weybridge, Surrey, Det Forenede Kongerige, KT15 2BH
    - Pfizer Investigational Site
  - Woking, Surrey, Det Forenede Kongerige, GU22 7EY
    - Pfizer Investigational Site
- Warwickshire
  - Rugby, Warwickshire, Det Forenede Kongerige, CV22 5PX
    - Pfizer Investigational Site
- Wiltshire
  - Warminster, Wiltshire, Det Forenede Kongerige, BA12 9AA
    - Pfizer Investigational Site
- Yorkshire
  - Sheffield, Yorkshire, Det Forenede Kongerige, S7 2DW
    - Pfizer Investigational Site
Estland
- - Pärnu, Estland, 80018
    - Pfizer Investigational Site
  - Tallinn, Estland, 10318
    - Pfizer Investigational Site
  - Tallinn, Estland, 11625
    - Pfizer Investigational Site
  - Tallinn, Estland, 13415
    - Pfizer Investigational Site
- Viljandi mk.
  - Viljandi, Viljandi mk., Estland, 71024
    - Pfizer Investigational Site
Finland
- - Kuopio, Finland, 70210
    - Pfizer Investigational Site
  - Lahti, Finland, 15110
    - Pfizer Investigational Site
  - Lohja, Finland, 08200
    - Pfizer Investigational Site
  - Oulu, Finland, 90100
    - Pfizer Investigational Site
Forenede Stater
- Alabama
  - Bay Minette, Alabama, Forenede Stater, 36507
    - Pfizer Investigational Site
  - Graysville, Alabama, Forenede Stater, 35073
    - Pfizer Investigational Site
  - Pell City, Alabama, Forenede Stater, 35125
    - Pfizer Investigational Site
  - Pell City, Alabama, Forenede Stater, 35128
    - Pfizer Investigational Site
- Arizona
  - Glendale, Arizona, Forenede Stater, 85306
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forenede Stater, 85006
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forenede Stater, 85016
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forenede Stater, 85028
    - Pfizer Investigational Site
  - Phoenix, Arizona, Forenede Stater, 85051
    - Pfizer Investigational Site
- Arkansas
  - Forrest City, Arkansas, Forenede Stater, 72335
    - Pfizer Investigational Site
- California
  - Berkeley, California, Forenede Stater, 94705
    - Pfizer Investigational Site
  - Concord, California, Forenede Stater, 94520
    - Pfizer Investigational Site
  - El Cajon, California, Forenede Stater, 92019
    - Pfizer Investigational Site
  - Encino, California, Forenede Stater, 91436
    - Pfizer Investigational Site
  - Fresno, California, Forenede Stater, 93720
    - Pfizer Investigational Site
  - Fullerton, California, Forenede Stater, 92835
    - Pfizer Investigational Site
  - Huntington Beach, California, Forenede Stater, 92648
    - Pfizer Investigational Site
  - Long Beach, California, Forenede Stater, 90806
    - Pfizer Investigational Site
  - Los Angeles, California, Forenede Stater, 90073
    - Pfizer Investigational Site
  - Rolling Hills Estates, California, Forenede Stater, 90274
    - Pfizer Investigational Site
  - San Diego, California, Forenede Stater, 92120
    - Pfizer Investigational Site
  - San Diego, California, Forenede Stater, 92128
    - Pfizer Investigational Site
  - San Jose, California, Forenede Stater, 95116
    - Pfizer Investigational Site
  - Santa Ana, California, Forenede Stater, 92704
    - Pfizer Investigational Site
  - Santa Barbara, California, Forenede Stater, 93105
    - Pfizer Investigational Site
  - Tustin, California, Forenede Stater, 92780
    - Pfizer Investigational Site
- Colorado
  - Denver, Colorado, Forenede Stater, 80220
    - Pfizer Investigational Site
  - Denver, Colorado, Forenede Stater, 80209
    - Pfizer Investigational Site
  - Denver, Colorado, Forenede Stater, 80206
    - Pfizer Investigational Site
  - Golden, Colorado, Forenede Stater, 80401
    - Pfizer Investigational Site
  - Longmont, Colorado, Forenede Stater, 80501
    - Pfizer Investigational Site
- Connecticut
  - Milford, Connecticut, Forenede Stater, 06460
    - Pfizer Investigational Site
- Delaware
  - Newark, Delaware, Forenede Stater, 19713
    - Pfizer Investigational Site
- District of Columbia
  - Washington, District of Columbia, Forenede Stater, 20010
    - Pfizer Investigational Site
  - Washington, District of Columbia, Forenede Stater, 20307
    - Pfizer Investigational Site
- Florida
  - Boca Raton, Florida, Forenede Stater, 33433
    - Pfizer Investigational Site
  - Chiefland, Florida, Forenede Stater, 32626
    - Pfizer Investigational Site
  - Green Cove Springs, Florida, Forenede Stater, 32043
    - Pfizer Investigational Site
  - Kissimmee, Florida, Forenede Stater, 34743
    - Pfizer Investigational Site
  - Lake City, Florida, Forenede Stater, 32025
    - Pfizer Investigational Site
  - Lake Mary, Florida, Forenede Stater, 32746
    - Pfizer Investigational Site
  - Miami, Florida, Forenede Stater, 33136
    - Pfizer Investigational Site
  - Opa Locka, Florida, Forenede Stater, 33054-3818
    - Pfizer Investigational Site
  - St. Cloud, Florida, Forenede Stater, 34769
    - Pfizer Investigational Site
  - Tampa, Florida, Forenede Stater, 33624
    - Pfizer Investigational Site
  - West Palm Beach, Florida, Forenede Stater, 33401
    - Pfizer Investigational Site
- Georgia
  - Atlanta, Georgia, Forenede Stater, 30342
    - Pfizer Investigational Site
  - Atlanta, Georgia, Forenede Stater, 30318-2513
    - Pfizer Investigational Site
  - Conyers, Georgia, Forenede Stater, 30013
    - Pfizer Investigational Site
  - Decatur, Georgia, Forenede Stater, 30035
    - Pfizer Investigational Site
- Hawaii
  - Honolulu, Hawaii, Forenede Stater, 96813
    - Pfizer Investigational Site
  - Honolulu, Hawaii, Forenede Stater, 96814
    - Pfizer Investigational Site
- Idaho
  - Hayden Lake, Idaho, Forenede Stater, 83835
    - Pfizer Investigational Site
- Illinois
  - Greenville, Illinois, Forenede Stater, 62246
    - Pfizer Investigational Site
  - Normal, Illinois, Forenede Stater, 61761
    - Pfizer Investigational Site
  - Olympia Fields, Illinois, Forenede Stater, 60461
    - Pfizer Investigational Site
  - Springfield, Illinois, Forenede Stater, 62704
    - Pfizer Investigational Site
- Indiana
  - Fishers, Indiana, Forenede Stater, 46038
    - Pfizer Investigational Site
  - Indianapolis, Indiana, Forenede Stater, 46229
    - Pfizer Investigational Site
  - Indianapolis, Indiana, Forenede Stater, 46254-5472
    - Pfizer Investigational Site
- Iowa
  - Des Moines, Iowa, Forenede Stater, 50314
    - Pfizer Investigational Site
  - Des Moines, Iowa, Forenede Stater, 50315
    - Pfizer Investigational Site
  - Dubuque, Iowa, Forenede Stater, 52002
    - Pfizer Investigational Site
- Kansas
  - Wichita, Kansas, Forenede Stater, 67203
    - Pfizer Investigational Site
- Kentucky
  - Louisville, Kentucky, Forenede Stater, 40213
    - Pfizer Investigational Site
  - Louisville, Kentucky, Forenede Stater, 40258
    - Pfizer Investigational Site
  - Mount Sterling, Kentucky, Forenede Stater, 40353
    - Pfizer Investigational Site
- Maryland
  - Baltimore, Maryland, Forenede Stater, 21204
    - Pfizer Investigational Site
  - Elkton, Maryland, Forenede Stater, 21921
    - Pfizer Investigational Site
  - Glen Burnie, Maryland, Forenede Stater, 21061
    - Pfizer Investigational Site
  - Wheaton, Maryland, Forenede Stater, 20902
    - Pfizer Investigational Site
- Massachusetts
  - Boston, Massachusetts, Forenede Stater, 02114
    - Pfizer Investigational Site
  - Springfield, Massachusetts, Forenede Stater, 01105
    - Pfizer Investigational Site
- Michigan
  - Ann Arbor, Michigan, Forenede Stater, 48104
    - Pfizer Investigational Site
  - Clinton, Michigan, Forenede Stater, 49236
    - Pfizer Investigational Site
  - Flint, Michigan, Forenede Stater, 48532
    - Pfizer Investigational Site
  - Muskegon, Michigan, Forenede Stater, 49444
    - Pfizer Investigational Site
- Minnesota
  - Saint Cloud, Minnesota, Forenede Stater, 56301
    - Pfizer Investigational Site
- Missouri
  - Kansas City, Missouri, Forenede Stater, 64116
    - Pfizer Investigational Site
  - Springfield, Missouri, Forenede Stater, 65807
    - Pfizer Investigational Site
- Nevada
  - Incline Village, Nevada, Forenede Stater, 89452
    - Pfizer Investigational Site
  - Las Vegas, Nevada, Forenede Stater, 89128
    - Pfizer Investigational Site
- New Jersey
  - Belvidere, New Jersey, Forenede Stater, 07823
    - Pfizer Investigational Site
  - New Brunswick, New Jersey, Forenede Stater, 08901
    - Pfizer Investigational Site
- New Mexico
  - Albuquerque, New Mexico, Forenede Stater, 87106
    - Pfizer Investigational Site
- New York
  - Albany, New York, Forenede Stater, 12208
    - Pfizer Investigational Site
  - Babylon, New York, Forenede Stater, 11702
    - Pfizer Investigational Site
  - Brooklyn, New York, Forenede Stater, 11224
    - Pfizer Investigational Site
  - Minneola, New York, Forenede Stater, 11501
    - Pfizer Investigational Site
  - New Hartford, New York, Forenede Stater, 13413
    - Pfizer Investigational Site
  - Syracuse, New York, Forenede Stater, 13210
    - Pfizer Investigational Site
  - Williamsville, New York, Forenede Stater, 14221
    - Pfizer Investigational Site
- North Carolina
  - Asheboro, North Carolina, Forenede Stater, 27203
    - Pfizer Investigational Site
  - Charlotte, North Carolina, Forenede Stater, 28227
    - Pfizer Investigational Site
  - Durham, North Carolina, Forenede Stater, 27713
    - Pfizer Investigational Site
  - Morehead City, North Carolina, Forenede Stater, 28557-3126
    - Pfizer Investigational Site
  - Raleigh, North Carolina, Forenede Stater, 27609
    - Pfizer Investigational Site
  - Tabor City, North Carolina, Forenede Stater, 28463
    - Pfizer Investigational Site
  - Winston-Salem, North Carolina, Forenede Stater, 27103
    - Pfizer Investigational Site
- Ohio
  - Columbus, Ohio, Forenede Stater, 43207
    - Pfizer Investigational Site
  - Dayton, Ohio, Forenede Stater, 45419
    - Pfizer Investigational Site
  - Kettering, Ohio, Forenede Stater, 45429
    - Pfizer Investigational Site
  - Marietta, Ohio, Forenede Stater, 45750
    - Pfizer Investigational Site
- Oregon
  - Portland, Oregon, Forenede Stater, 97210
    - Pfizer Investigational Site
  - Portland, Oregon, Forenede Stater, 97232
    - Pfizer Investigational Site
- Pennsylvania
  - Fogelsville, Pennsylvania, Forenede Stater, 18051
    - Pfizer Investigational Site
  - Hanover, Pennsylvania, Forenede Stater, 17331
    - Pfizer Investigational Site
  - Harrisburg, Pennsylvania, Forenede Stater, 17112
    - Pfizer Investigational Site
  - Jeannette, Pennsylvania, Forenede Stater, 15644
    - Pfizer Investigational Site
  - Jersey Shore, Pennsylvania, Forenede Stater, 17740
    - Pfizer Investigational Site
  - Lansdale, Pennsylvania, Forenede Stater, 19446
    - Pfizer Investigational Site
  - Melrose Park, Pennsylvania, Forenede Stater, 19027
    - Pfizer Investigational Site
  - Philadelphia, Pennsylvania, Forenede Stater, 19153-2326
    - Pfizer Investigational Site
- South Carolina
  - Charleston, South Carolina, Forenede Stater, 29412
    - Pfizer Investigational Site
  - North Myrtle Beach, South Carolina, Forenede Stater, 29582
    - Pfizer Investigational Site
- Texas
  - Beaumont, Texas, Forenede Stater, 77701
    - Pfizer Investigational Site
  - Dallas, Texas, Forenede Stater, 75246
    - Pfizer Investigational Site
  - Houston, Texas, Forenede Stater, 77008
    - Pfizer Investigational Site
  - Houston, Texas, Forenede Stater, 77079
    - Pfizer Investigational Site
  - Kaufman, Texas, Forenede Stater, 75142
    - Pfizer Investigational Site
  - San Antonio, Texas, Forenede Stater, 78229
    - Pfizer Investigational Site
  - San Marcos, Texas, Forenede Stater, 78666
    - Pfizer Investigational Site
  - Stephenville, Texas, Forenede Stater, 76401
    - Pfizer Investigational Site
  - Webster, Texas, Forenede Stater, 77598
    - Pfizer Investigational Site
- Vermont
  - South Burlington, Vermont, Forenede Stater, 05403
    - Pfizer Investigational Site
- Virginia
  - Richmond, Virginia, Forenede Stater, 23225-4017
    - Pfizer Investigational Site
  - Richmond, Virginia, Forenede Stater, 23294
    - Pfizer Investigational Site
- Washington
  - Federal Way, Washington, Forenede Stater, 98003
    - Pfizer Investigational Site
  - Spokane, Washington, Forenede Stater, 99204
    - Pfizer Investigational Site
  - Spokane, Washington, Forenede Stater, 99207
    - Pfizer Investigational Site
- West Virginia
  - Burnsville, West Virginia, Forenede Stater, 26335
    - Pfizer Investigational Site
Frankrig
- - Amiens cedex 1, Frankrig, 80094
    - Pfizer Investigational Site
  - Armentieres, Frankrig, 59427
    - Pfizer Investigational Site
  - Besancon, Frankrig, 25030
    - Pfizer Investigational Site
  - Bondy Cedex, Frankrig, 93143
    - Pfizer Investigational Site
  - Brest CEDEX, Frankrig, 29609
    - Pfizer Investigational Site
  - Chartres, Frankrig, 28000
    - Pfizer Investigational Site
  - Corbeil-Essonnes, Frankrig, 91100
    - Pfizer Investigational Site
  - Lorient Cedex, Frankrig, 56322
    - Pfizer Investigational Site
  - Paris Cedex 10, Frankrig, 75475
    - Pfizer Investigational Site
  - Paris Cedex 18, Frankrig, 75877
    - Pfizer Investigational Site
  - Rennes Cedex 2, Frankrig, 35203
    - Pfizer Investigational Site
Grækenland
- - Athens, Grækenland, 11527
    - Pfizer Investigational Site
  - Athens, Grækenland, 15123
    - Pfizer Investigational Site
  - Thessaloniki, Grækenland, 546 36
    - Pfizer Investigational Site
Holland
- - 's Hertogenbosch, Holland, 5211 RW
    - Pfizer Investigational Site
  - Amsterdam, Holland, 1105 AZ
    - Pfizer Investigational Site
  - Beek, Holland, 6191 JW
    - Pfizer Investigational Site
  - Eindhoven, Holland, 5631 BM
    - Pfizer Investigational Site
  - Venlo, Holland, 5912 BL
    - Pfizer Investigational Site
Italien
- - Catania, Italien, 95122
    - Pfizer Investigational Site
  - Genova, Italien, 16132
    - Pfizer Investigational Site
  - Milano, Italien, 20132
    - Pfizer Investigational Site
  - Napoli, Italien, 80131
    - Pfizer Investigational Site
  - Padova, Italien, 35128
    - Pfizer Investigational Site
  - Palermo, Italien, 90127
    - Pfizer Investigational Site
  - Roma, Italien, 00133
    - Pfizer Investigational Site
  - Udine, Italien, 33100
    - Pfizer Investigational Site
Kroatien
- - Zagreb, Kroatien, 10000
    - Pfizer Investigational Site
  - Zagreb, Kroatien, 10 000
    - Pfizer Investigational Site
Mexico
- Jalisco
  - Guadalajara, Jalisco, Mexico, 44340
    - Pfizer Investigational Site
- Nuevo Leon
  - Monterrey, Nuevo Leon, Mexico, 64460
    - Pfizer Investigational Site
Norge
- - Fornebu, Norge, 1364
    - Pfizer Investigational Site
  - Honefoss, Norge, 3515
    - Pfizer Investigational Site
  - Skedsmokorset, Norge, N-2020
    - Pfizer Investigational Site
  - Stavanger, Norge, 4068
    - Pfizer Investigational Site
Polen
- - Lask, Polen, 98-100
    - Pfizer Investigational Site
  - Lodz, Polen, 93-338
    - Pfizer Investigational Site
  - Lublin, Polen, 20-536
    - Pfizer Investigational Site
  - Warszawa, Polen, 02-097
    - Pfizer Investigational Site
Portugal
- - Aveiro, Portugal, 3814-096
    - Pfizer Investigational Site
  - Lisboa, Portugal, 1250-203
    - Pfizer Investigational Site
  - Lisboa, Portugal, 1349-019
    - Pfizer Investigational Site
  - Porto, Portugal, 4099-001
    - Pfizer Investigational Site
  - Torres Vedras, Portugal, 2560-324
    - Pfizer Investigational Site
Slovakiet
- - Banska Bystrica, Slovakiet, 975 17
    - Pfizer Investigational Site
  - Bratislava, Slovakiet, 811 08
    - Pfizer Investigational Site
  - Martin, Slovakiet, 036 01
    - Pfizer Investigational Site
Spanien
- - Barcelona, Spanien, 08036
    - Pfizer Investigational Site
  - Granada, Spanien, 18012
    - Pfizer Investigational Site
  - Madrid, Spanien, 28935
    - Pfizer Investigational Site
  - Malaga, Spanien, 07300
    - Pfizer Investigational Site
  - Sevilla, Spanien, 41014
    - Pfizer Investigational Site
  - Valencia, Spanien, 46015
    - Pfizer Investigational Site
- A Coruña
  - Santiago de Compostela, A Coruña, Spanien, 15706
    - Pfizer Investigational Site
- Barcelona
  - Badalona, Barcelona, Spanien, 08916
    - Pfizer Investigational Site
- Las Palmas de Gran Canaria
  - Las Palmas, Las Palmas de Gran Canaria, Spanien, 35016
    - Pfizer Investigational Site
- Santa Cruz de Tenerife
  - La Laguna, Santa Cruz de Tenerife, Spanien, 38320
    - Pfizer Investigational Site
- Valencia
  - Alzira, Valencia, Spanien, 46600
    - Pfizer Investigational Site
- Vizcaya
  - Bilbao, Vizcaya, Spanien, 48013
    - Pfizer Investigational Site
Sverige
- - Boras, Sverige, 503 30
    - Pfizer Investigational Site
  - Forshaga, Sverige, 667 32
    - Pfizer Investigational Site
  - Goteborg, Sverige, 412 55
    - Pfizer Investigational Site
  - Goteborg, Sverige, 41665
    - Pfizer Investigational Site
  - Göteborg, Sverige, 417 17
    - Pfizer Investigational Site
  - Harnosand, Sverige, 871 82
    - Pfizer Investigational Site
  - Helsingborg, Sverige, 251 87
    - Pfizer Investigational Site
  - Linkoping, Sverige, 581 85
    - Pfizer Investigational Site
  - Malmo, Sverige, 211 52
    - Pfizer Investigational Site
  - Stockholm, Sverige, 171 76
    - Pfizer Investigational Site
  - Vaxjo, Sverige, 351 85
    - Pfizer Investigational Site
Sydafrika
- Gauteng
  - Houghton, Gauteng, Sydafrika, 2198
    - Pfizer Investigational Site
- KwaZulu Natal
  - Umhlanga Rocks, KwaZulu Natal, Sydafrika, 4320
    - Pfizer Investigational Site
Tyskland
- - Altenburg, Tyskland, 04600
    - Pfizer Investigational Site
  - Aschaffenburg, Tyskland, 63739
    - Pfizer Investigational Site
  - Bad Doberan, Tyskland, 18209
    - Pfizer Investigational Site
  - Berlin, Tyskland, 10115
    - Pfizer Investigational Site
  - Berlin, Tyskland, 13355
    - Pfizer Investigational Site
  - Bonn, Tyskland, 53179
    - Pfizer Investigational Site
  - Chemnitz, Tyskland, 09130
    - Pfizer Investigational Site
  - Datteln, Tyskland, 45711
    - Pfizer Investigational Site
  - Dortmund, Tyskland, 44339
    - Pfizer Investigational Site
  - Eisenach, Tyskland, 99817
    - Pfizer Investigational Site
  - Emden, Tyskland, 26725
    - Pfizer Investigational Site
  - Essen, Tyskland, 45329
    - Pfizer Investigational Site
  - Falkensee, Tyskland, 14612
    - Pfizer Investigational Site
  - Friedberg, Tyskland, 86316
    - Pfizer Investigational Site
  - Fulda, Tyskland, 36037
    - Pfizer Investigational Site
  - Hamburg, Tyskland, 21073
    - Pfizer Investigational Site
  - Hohenmoelsen, Tyskland, 06679
    - Pfizer Investigational Site
  - Leipzig, Tyskland, 04103
    - Pfizer Investigational Site
  - Leverkusen, Tyskland, 51371
    - Pfizer Investigational Site
  - Marl, Tyskland, 45770
    - Pfizer Investigational Site
  - Meissen, Tyskland, 01662
    - Pfizer Investigational Site
  - Mittweida, Tyskland, 09648
    - Pfizer Investigational Site
  - Muenchen, Tyskland, D-80469
    - Pfizer Investigational Site
  - Muenster, Tyskland, 48145
    - Pfizer Investigational Site
  - Muenster, Tyskland, 48153
    - Pfizer Investigational Site
  - Neuss, Tyskland, 41460
    - Pfizer Investigational Site
  - Reinfeld, Tyskland, 23858
    - Pfizer Investigational Site
  - Riesa, Tyskland, 01587
    - Pfizer Investigational Site
  - Rossach, Tyskland, 96269
    - Pfizer Investigational Site
  - Schluechtern, Tyskland, 36381
    - Pfizer Investigational Site
  - Siegen, Tyskland, 57072
    - Pfizer Investigational Site
  - Suhl, Tyskland, 98529
    - Pfizer Investigational Site
  - Surwold, Tyskland, 26903
    - Pfizer Investigational Site
  - Villingen-Schwenningen, Tyskland, 78054
    - Pfizer Investigational Site
  - Wangen, Tyskland, 88239
    - Pfizer Investigational Site
  - Wangen / Allgaeu, Tyskland, 88239
    - Pfizer Investigational Site
  - Warburg, Tyskland, 34414
    - Pfizer Investigational Site
  - Wiesbaden, Tyskland, 65191
    - Pfizer Investigational Site
Østrig
- - Vienna, Østrig, A-1130
    - Pfizer Investigational Site
  - Wien, Østrig, A-1030
    - Pfizer Investigational Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

All subjects who participated in a controlled trial of Exubera active within the last five years (17 protocols total)

Beskrivelse

Inclusion Criteria:

Previously participated in an eligible Exubera clinical trial
Willing to provide study doctor with at least one alternate contact person

Exclusion Criteria:

Participated in an investigational study of an unapproved drug since completing the Exubera trial
Ever used an other (non-Exubera) inhaled insulin

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Observationsmodeller: Kohorte

Kohorter og interventioner

Gruppe / kohorte Gruppe / kohorte En gruppe eller undergruppe af deltagere i et observationsstudie, der vurderes for biomedicinske eller sundhedsmæssige resultater.	Intervention / Behandling Intervention / Behandling En proces eller handling, der er i fokus for en klinisk undersøgelse. Interventioner omfatter lægemidler, medicinsk udstyr, procedurer, vacciner og andre produkter, der enten er til undersøgelse eller allerede er tilgængelige. Interventioner kan også omfatte ikke-invasive tilgange, såsom uddannelse eller ændring af kost og motion.
Previously treated with Exubera	Medicin: Exubera Subjects who had been treated with Exubera in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).
Previously treated with comparator Subjects who had been treated with a comparator (other diabetes treatment such as injected insulin) in a prior Exubera controlled trial.	Andet: Randomized diabetes therapy Subjects who had been treated with a comparator (other diabetes treatment including one or more of: subcutaneous insulin, sulfonylureas, biguanides, or thiazolinediones) in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Gruppe / kohorte

Intervention / Behandling

Previously treated with Exubera

Medicin: Exubera

Subjects who had been treated with Exubera in a prior Exubera controlled trial. Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Previously treated with comparator

Subjects who had been treated with a comparator (other diabetes treatment such as injected insulin) in a prior Exubera controlled trial.

Andet: Randomized diabetes therapy

Subjects who had been treated with a comparator (other diabetes treatment including one or more of: subcutaneous insulin, sulfonylureas, biguanides, or thiazolinediones) in a prior Exubera controlled trial.

Following initial use of randomized treatment, physicians and subjects were free to change regimens and dosing based on subject response to assigned treatment (as consistent with routine practice).

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål	Foranstaltningsbeskrivelse	Tidsramme
Rate of Primary Lung Cancer Mortality Tidsramme: Baseline from original trial up to Year 2 of this study	Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information. Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality. Includes events from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study

Sekundære resultatmål

Resultatmål	Foranstaltningsbeskrivelse	Tidsramme
Rate of Primary Lung Cancer Mortality Among Former Smokers Tidsramme: Baseline from original trial up to Year 2 of this study	Reported deaths from primary lung cancer were adjudicated and classified into 4 categories: highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer); likely (some information may have been missing for definite diagnosis); unlikely; insufficient information. Highly likely and likely cases used to report rate and rate ratio of primary lung cancer mortality. Includes events from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study
Rate of All-cause Mortality Tidsramme: Baseline from original trial up to Year 2 of this study	The rate and rate ratio of all-cause mortality that occurred anytime from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study
Rate of Primary Lung Cancer Diagnosis Tidsramme: Baseline from original trial up to Year 2 of this study	The rate and rate ratio of lung cancer adjudicated as highly likely (clinical, radiographic, and/or histological data consistent with primary lung cancer) or likely (some information may have been missing for definite diagnosis) to be newly diagnosed primary lung cancer that occurred anytime from the start of the original trial to the end of FUSE.	Baseline from original trial up to Year 2 of this study

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Pfizer

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Gatto NM, Koralek DO, Bracken MB, Duggan WT, Lem J, Klioze S, Koch GG, Wise RA, Cohen RB, Jackson NC. Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results. Diabetes Care. 2019 Sep;42(9):1708-1715. doi: 10.2337/dc18-2529. Epub 2019 Jul 22.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. august 2008

Primær færdiggørelse (Faktiske)

1. januar 2012

Studieafslutning (Faktiske)

1. januar 2012

Datoer for studieregistrering

Først indsendt

12. august 2008

Først indsendt, der opfyldte QC-kriterier

12. august 2008

Først opslået (Skøn)

14. august 2008

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

23. oktober 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. september 2012

Sidst verificeret

1. september 2012

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Observational Study Exubera

Andre undersøgelses-id-numre

A2171121

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Diabetes mellitus

NCT02722499

Afsluttet

Økonomiske incitamenter Telefonisk uddannelse og færdighedsprøve hos afroamerikanere med diabetes (FITEST) (FITEST)

Diabetes mellitus | Type 2 diabetes mellitus | Voksen-debuterende diabetes mellitus | Ikke-insulinafhængig diabetes mellitus | Ikke-insulinafhængig diabetes mellitus, type II
NCT05168657

Afsluttet

Gennemførlighed af lukket sløjfe automatiseret insulinleveringssystem af primær pleje og endokrinologi, personligt og via telesundhed

Diabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinafhængig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1
NCT03211858

Afsluttet

Sammenligning af SAR341402 med NovoLog/NovoRapid hos voksne patienter med diabetes mellitus, der også bruger Insulin Glargine (GEMELLI1)

Type 1-diabetes mellitus-type 2-diabetes mellitus
NCT07228117

Rekruttering

GATEWAY: Sikkerhedsvurdering af MiniMed™ NMX8-AID-systemet til børn og voksne med diabetes

Type 2 diabetes mellitus | Type 1 diabetes mellitus
NCT03811470

Rekruttering

Kina Diabetes Registry af Metabolic Management Center (CDR-MMC)

Type 2 diabetes mellitus | Type 1 diabetes mellitus | Monogenetisk diabetes | Pancreatogen diabetes | Lægemiddel-induceret diabetes mellitus | Andre former for diabetes mellitus
NCT02103595

Afsluttet

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Diabetes mellitus type 2, diabetes mellitus type 1
NCT00563004

Afsluttet

Effekten af DBcare, et kosttilskud på diabeteskontrol

Diabetes mellitus type 2 | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, om oral hypoglykæmisk behandling | Voksen type diabetes mellitus
NCT01781975

Afsluttet

Imatinib-behandling ved nyligt opstået type 1-diabetes mellitus

Type 1 diabetes mellitus | Diabetes mellitus, type I | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1 | IDDM
NCT04129424

Ukendt

Foreløbig undersøgelse af de operationelle standarder for insulinpumpeinstallation i diabetesklinikken i Kina

Type 2 diabetes mellitus | Type 1 diabetes mellitus | Svangerskabsdiabetes mellitus | Pancreatogen diabetes mellitus | Prægestationsdiabetes mellitus | Diabetespatienter i perioperativ periode
NCT06852950

Rekruttering

Kontinuerlig glukoseovervågning for ambulant diabeteshåndtering efter udskrivning på hospitalet

Hyperglykæmi | Type 2 diabetes mellitus (T2DM) | Type 1 diabetes mellitus (T1DM)

Kliniske forsøg med Exubera

NCT00143247

Afsluttet

Langsigtet sikkerhedsundersøgelse af inhaleret insulin: En op til fire års forlængelse af terapi hos personer med type 1 eller type 2 diabetes mellitus

Diabetes mellitus
NCT00359801

Afsluttet

Exubera stort enkelt forsøg til evaluering af langsigtet lunge- og kardiovaskulær sikkerhed (VOLUME)

Diabetes mellitus
NCT00348374

Afsluttet

Exubera vs Lispro i et Lantus-baseret regime til forbedret glykæmisk kontrol ved type 2-diabetes

Diabetes mellitus
NCT00282971

Afsluttet

Et klinisk forsøg, der vurderer indvirkningen af inhaleret insulin på glukosekontrol hos patienter med type 2-diabetes mellitus

Diabetes mellitus type 2
NCT00437489

Afsluttet

Et klinisk forsøg, der sammenligner effektiviteten og sikkerheden af 2 forskellige indledende dosisrecepter for Exubera.

Diabetes mellitus, type 2
NCT00479258

Afsluttet

Sikkerhed og effektivitet af Exubera sammenlignet med subkutan human insulinterapi hos børn og unge

Diabetes mellitus, type 1
NCT00367445

Afsluttet

Et klinisk forsøg, der sammenligner kortsigtet effektivitet og sikkerhed af Exubera og Lantus

Diabetes mellitus, type 2
NCT00356421

Afsluttet

Et klinisk forsøg, der sammenligner effektivitet og sikkerhed af Exubera® og Humalog®

Diabetes mellitus, type 1
NCT00391027

Afsluttet

Et klinisk forsøg, der sammenligner effektiviteten og sikkerheden af Exubera® og Lantus®

Diabetes mellitus, type 2
NCT00246623

Afsluttet

Amerikansk inhaleret insulindosistitreringsundersøgelse

Diabetes mellitus, type 2

Follow-Up Study for Exubera (FUSE)

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

Studieoversigt

Status

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Undersøgelsestype

Tilmelding (Faktiske)

Kontakter og lokationer

Studiesteder

Deltagelseskriterier

Berettigelseskriterier

Aldre berettiget til at studere

Tager imod sunde frivillige

Køn, der er berettiget til at studere

Prøveudtagningsmetode

Studiebefolkning

Beskrivelse

Studieplan

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Antal grupper/kohorter

Kohorter og interventioner

Gruppe / kohorte

Intervention / Behandling

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål

Foranstaltningsbeskrivelse

Tidsramme

Sekundære resultatmål

Resultatmål

Foranstaltningsbeskrivelse

Tidsramme

Samarbejdspartnere og efterforskere

Sponsor

Publikationer og nyttige links

Generelle publikationer

Datoer for undersøgelser

Studer store datoer

Studiestart

Primær færdiggørelse (Faktiske)

Studieafslutning (Faktiske)

Datoer for studieregistrering

Først indsendt

Først indsendt, der opfyldte QC-kriterier

Først opslået (Skøn)

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

Sidst verificeret

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

Kliniske forsøg med Diabetes mellitus

Kliniske forsøg med Exubera

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer